In an interview with Mother Board, journalist Robert Whitaker discusses the troublesome relationship between big pharmaceutical companies and the medical professionals who prescribe drugs meant to treat mental disorders.
Whitaker explores that relationship in his book Anatomy of an Epidemic. He said he first came across evidence casting doubt on the “chemical imbalance” theory of psychiatric illness when he was doing research for a Boston Globe series.
In the interview, Whitaker pointed ...
continue reading...
A piece in the Denver Post faults the U.S. Food and Drug Administration’s minimal monitoring of medical devices, and says the existing system leads to injuries and deaths from faulty devices allowed to remain on the market.
An NPR report on an Arkansas jury’s billion-dollar decision against Johnson & Johnson mentions that the company is most famous for its baby shampoo and wryly notes: “So much for no more tears.”
In a motion filed as part of a fraud case against Johnson & Johnson, the federal government alleges that new company CEO Alex Gorsky “was actively involved in matters at issue in this case,” Forbes reports.
In a piece in Canadian magazine Common Ground, University of Victoria drug policy researcher Alan Cassels questions whether pregnant women in Canada are getting adequate warnings about drugs they’re taking during pregnancy.
